Embla Medical hf

OCSE:EMBLA (Iceland)  
kr 28.50 (0%) May 24
30.65
P/B:
2.42
Market Cap:
kr 12.17B ($ 1.77B)
Enterprise V:
kr 15.50B ($ 2.25B)
Volume:
38.13K
Avg Vol (2M):
43.48K
Also Trade In:
Volume:
38.13K
Avg Vol (2M):
43.48K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Embla Medical hf ( ) from 2009 to May 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Embla Medical hf stock (OCSE:EMBLA) PE ratio as of May 26 2024 is 30.65. More Details

Embla Medical hf (OCSE:EMBLA) PE Ratio (TTM) Chart

To

Embla Medical hf (OCSE:EMBLA) PE Ratio (TTM) Historical Data

Total 1251
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Embla Medical hf PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-26 30.6 2024-03-15 34.1
2024-05-24 30.6 2024-03-14 34.2
2024-05-23 30.6 2024-03-13 33.9
2024-05-22 31.0 2024-03-12 33.3
2024-05-21 30.8 2024-03-11 34.1
2024-05-17 30.9 2024-03-08 33.1
2024-05-16 31.6 2024-03-07 32.5
2024-05-15 32.0 2024-03-06 32.1
2024-05-14 31.0 2024-03-05 32.4
2024-05-13 31.3 2024-03-04 32.1
2024-05-08 31.2 2024-03-01 32.8
2024-05-07 31.7 2024-02-29 33.3
2024-05-06 31.9 2024-02-28 32.2
2024-05-03 31.7 2024-02-27 32.5
2024-05-02 31.5 2024-02-26 32.4
2024-05-01 32.1 2024-02-23 33.3
2024-04-30 31.2 2024-02-22 33.4
2024-04-29 31.9 2024-02-21 33.8
2024-04-26 31.4 2024-02-20 34.3
2024-04-25 31.4 2024-02-19 34.1
2024-04-24 33.1 2024-02-16 34.1
2024-04-23 33.0 2024-02-15 33.9
2024-04-22 32.4 2024-02-14 34.3
2024-04-19 33.1 2024-02-13 33.9
2024-04-18 31.7 2024-02-12 33.2
2024-04-17 32.7 2024-02-09 32.3
2024-04-16 32.0 2024-02-08 32.7
2024-04-15 31.8 2024-02-07 33.2
2024-04-12 32.3 2024-02-06 34.1
2024-04-11 32.3 2024-02-05 33.9
2024-04-10 32.5 2024-02-02 31.9
2024-04-09 32.8 2024-02-01 31.0
2024-04-08 32.8 2024-01-31 31.0
2024-04-05 32.8 2024-01-30 30.7
2024-04-04 34.0 2024-01-29 29.4
2024-04-03 33.4 2024-01-26 30.1
2024-04-02 35.0 2024-01-25 30.5
2024-03-27 34.6 2024-01-24 30.9
2024-03-26 34.7 2024-01-23 30.9
2024-03-25 35.5 2024-01-22 31.0
2024-03-22 35.6 2024-01-19 30.4
2024-03-21 34.9 2024-01-18 29.8
2024-03-20 34.8 2024-01-17 29.6
2024-03-19 34.6 2024-01-16 29.5
2024-03-18 34.4 2024-01-15 29.4

Embla Medical hf (OCSE:EMBLA) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Embla Medical hf is a provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels..